comparemela.com

Latest Breaking News On - Cantex pharmaceuticals inc - Page 1 : comparemela.com

CANTEX PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR AZELIRAGON FOR THE TREATMENT OF PANCREATIC CANCER

Cantex Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on developing transformative therapies for cancer and other life-threatening medical conditions for which new treatments are urgently needed, announced today that the U.S..

Casey-mcdonald
Stepheng-marcus
Daniel-kontoh-boateng
Juanf-rodriguez
Cantex-pharmaceuticals-inc
Drug-administration
Nasdaq
Tv-therapeutics-inc
Cantex-pharmaceuticals
Orphan-drug-designation
Chief-executive-officer

CANTEX PHARMACEUTICALS TO PARTICIPATE IN THE BIO CEO & INVESTOR CONFERENCE

/PRNewswire/ Cantex Pharmaceuticals, Inc., a clinical stage pharmaceutical company focused on developing transformative therapies for cancer and other.

New-york
United-states
Marriott-marquis
Daniel-kontoh-boateng
Juanf-rodriguez
Stephen-marcus
Casey-mcdonald
Stepheng-marcus
Nasdaq
Tv-therapeutics-inc
Cantex-pharmaceuticals-inc
Prnewswire-cantex-pharmaceuticals-inc

Cantex and Allegheny Health Network Announce Initiation of a Phase 1/2 Study of Azeliragon in Patients Refractory to First-Line Treatment of Metastatic Pancreatic Cancer

Cantex Pharmaceuticals, Inc., a clinical stage pharmaceutical company focused on developing transformative therapies for cancer and other life-threatening medical conditions for which new treatments are urgently needed, and Allegheny Health Network, an academic healthcare system serving the diverse greater western Pennsylvania community that provides pioneering medical research and education programs focused on transforming healthcare, today announced the initiation of a Phase 1/2 study to assess the safety and efficacy of azeliragon in patients refractory to first-line treatment of metastatic pancreatic cancer.

Pennsylvania
United-states
Stepheng-marcus
Nathan-bahary
Tv-therapeutics-inc
Eastern-cooperative-oncology-group
Cantex-pharmaceuticals-inc
Oncology-at-allegheny-health-network-cancer-institute
National-cancer-institute
Ecog-gi-steering-committee
Allegheny-health-network
Nasdaq

CANTEX AND MICHIGAN MEDICINE ANNOUNCE INITIATION OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PHASE 3 PIVOTAL CLINICAL TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF AZELIRAGON IN THE TREATMENT OF PATIENTS HOSPITALIZED FOR COVID-19

WESTON, Fla. and ANN ARBOR, Mich., Sept. 27, 2023 /PRNewswire/ Cantex Pharmaceuticals, Inc., a clinical stage pharmaceutical company focused on developing transformative therapies for cancer and.

Michigan
United-states
Salim-hayek
Juanf-rodriguez
Casey-mcdonald
Stepheng-marcus
Daniel-kontoh-boateng
Nasdaq
University-of-michigan
Tv-therapeutics-inc
Frankel-cardiovascular-center
University-of-michigan-health

CANTEX AND MICHIGAN MEDICINE ANNOUNCE INITIATION OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PHASE 3 PIVOTAL CLINICAL TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF AZELIRAGON IN THE TREATMENT OF PATIENTS HOSPITALIZED FOR COVID-19

CANTEX AND MICHIGAN MEDICINE ANNOUNCE INITIATION OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PHASE 3 PIVOTAL CLINICAL TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF AZELIRAGON IN THE TREATMENT OF PATIENTS HOSPITALIZED FOR COVID-19
yoursourceone.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yoursourceone.com Daily Mail and Mail on Sunday newspapers.

Michigan
United-states
Salim-hayek
Casey-mcdonald
Daniel-kontoh-boateng
Juanf-rodriguez
Stepheng-marcus
Kellogg-eye-center
University-hospital
Rogel-cancer-center
University-of-michigan
Tv-therapeutics-inc
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.